158 related articles for article (PubMed ID: 29924223)
1. Melanoma: clinical, evolutive and histopathological characteristics of a series of 136 cases.
Ocanha-Xavier JP; Xavier-Junior JCC; Marques MEA
An Bras Dermatol; 2018 Jun; 93(3):373-376. PubMed ID: 29924223
[TBL] [Abstract][Full Text] [Related]
2. Does the morphology of cutaneous melanoma help to explain the international differences in survival? Results from 1 578 482 adults diagnosed during 2000-2014 in 59 countries (CONCORD-3).
Di Carlo V; Stiller CA; Eisemann N; Bordoni A; Matz M; Curado MP; Daubisse-Marliac L; Valkov M; Bulliard JL; Morrison D; Johnson C; Girardi F; Marcos-Gragera R; Šekerija M; Larønningen S; Sirri E; Coleman MP; Allemani C;
Br J Dermatol; 2022 Sep; 187(3):364-380. PubMed ID: 35347700
[TBL] [Abstract][Full Text] [Related]
3. Imiquimod 5% cream as primary or adjuvant therapy for melanoma in situ, lentigo maligna type.
Swetter SM; Chen FW; Kim DD; Egbert BM
J Am Acad Dermatol; 2015 Jun; 72(6):1047-53. PubMed ID: 25791801
[TBL] [Abstract][Full Text] [Related]
4. Comparison between lentigo maligna melanoma and other histogenetic types of malignant melanoma of the head and neck. Scottish Melanoma Group.
Cox NH; Aitchison TC; Sirel JM; MacKie RM
Br J Cancer; 1996 Apr; 73(7):940-4. PubMed ID: 8611411
[TBL] [Abstract][Full Text] [Related]
5. Comparison of surgical margins for lentigo maligna versus melanoma in situ.
Kunishige JH; Doan L; Brodland DG; Zitelli JA
J Am Acad Dermatol; 2019 Jul; 81(1):204-212. PubMed ID: 31014825
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological characteristics of 270 patients with lentigo maligna and lentigo maligna melanoma: data from a German skin cancer centre.
Gambichler T; Kempka J; Kampilafkos P; Bechara FG; Altmeyer P; Stücker M
Br J Dermatol; 2014 Dec; 171(6):1605-7. PubMed ID: 24958545
[No Abstract] [Full Text] [Related]
7. Lentigo maligna: melanoma in situ on chronically sun-damaged skin.
Reed JA; Shea CR
Arch Pathol Lab Med; 2011 Jul; 135(7):838-41. PubMed ID: 21732771
[TBL] [Abstract][Full Text] [Related]
8. High regional mortality due to malignant melanoma in Eastern Finland may be explained by the increase in aggressive melanoma types.
Suhonen V; Rummukainen J; Siiskonen H; Mannermaa A; Harvima IT
BMC Cancer; 2021 Oct; 21(1):1155. PubMed ID: 34711205
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of exon 15 BRAF mutations in primary melanoma of the superficial spreading, nodular, acral, and lentigo maligna subtypes.
Lang J; MacKie RM
J Invest Dermatol; 2005 Sep; 125(3):575-9. PubMed ID: 16117801
[TBL] [Abstract][Full Text] [Related]
10. Value of anatomic site, histology and clinicopathological parameters for prediction of lymph node metastasis and overall survival in head and neck melanomas.
Ettl T; Irga S; Müller S; Rohrmeier C; Reichert TE; Schreml S; Gosau M
J Craniomaxillofac Surg; 2014 Jul; 42(5):e252-8. PubMed ID: 24216129
[TBL] [Abstract][Full Text] [Related]
11. Melanoma in Mexico: Clinicopathologic Features in a Population with Predominance of Acral Lentiginous Subtype.
Lino-Silva LS; Domínguez-Rodríguez JA; Aguilar-Romero JM; Martínez-Said H; Salcedo-Hernández RA; García-Pérez L; Herrera-Gómez Á; Cuellar-Hubbe M
Ann Surg Oncol; 2016 Dec; 23(13):4189-4194. PubMed ID: 27401447
[TBL] [Abstract][Full Text] [Related]
12. Malignant melanoma in Taiwan: a prognostic study of 181 cases.
Chang JW; Yeh KY; Wang CH; Yang TS; Chiang HF; Wei FC; Kuo TT; Yang CH
Melanoma Res; 2004 Dec; 14(6):537-41. PubMed ID: 15577327
[TBL] [Abstract][Full Text] [Related]
13. Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005.
Bradford PT; Goldstein AM; McMaster ML; Tucker MA
Arch Dermatol; 2009 Apr; 145(4):427-34. PubMed ID: 19380664
[TBL] [Abstract][Full Text] [Related]
14. TERT gene amplification is associated with poor outcome in acral lentiginous melanoma.
Diaz A; Puig-Butillé JA; Muñoz C; Costa D; Díez A; Garcia-Herrera A; Carrera C; Badenas C; Solé F; Malvehy J; Puig S; Alos L
J Am Acad Dermatol; 2014 Oct; 71(4):839-41. PubMed ID: 25219713
[No Abstract] [Full Text] [Related]
15. Melanoma--clinical, dermatoscopical, and histopathological morphological characteristics.
Situm M; Buljan M; Kolić M; Vučić M
Acta Dermatovenerol Croat; 2014; 22(1):1-12. PubMed ID: 24813835
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and prognosis of Asian patients with acral lentiginous melanoma who have nodal nevi in their sentinel lymph node biopsy specimen.
Kim HJ; Seo JW; Roh MS; Lee JH; Song KH
J Am Acad Dermatol; 2018 Oct; 79(4):706-713. PubMed ID: 29673774
[TBL] [Abstract][Full Text] [Related]
17. [Dubreuilh melanoma: and epidemiologic and prognostic study].
Tournillac I; Picot MC; Dereure O; Guilhou JJ; Guillot B
Ann Dermatol Venereol; 1999 Oct; 126(10):676-80. PubMed ID: 10604003
[TBL] [Abstract][Full Text] [Related]
18. A quantitative systematic review of the efficacy of imiquimod monotherapy for lentigo maligna and an analysis of factors that affect tumor clearance.
Mora AN; Karia PS; Nguyen BM
J Am Acad Dermatol; 2015 Aug; 73(2):205-12. PubMed ID: 26088690
[TBL] [Abstract][Full Text] [Related]
19. The "spaghetti technique": an alternative to Mohs surgery or staged surgery for problematic lentiginous melanoma (lentigo maligna and acral lentiginous melanoma).
Gaudy-Marqueste C; Perchenet AS; Taséi AM; Madjlessi N; Magalon G; Richard MA; Grob JJ
J Am Acad Dermatol; 2011 Jan; 64(1):113-8. PubMed ID: 21167406
[TBL] [Abstract][Full Text] [Related]
20. Unusual variants of melanoma: fact or fiction?
Sagebiel RW
Semin Oncol; 1996 Dec; 23(6):703-8. PubMed ID: 8970590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
